VICTORY CAPITAL MANAGEMENT INC

Position in MDXG — Mimedx Group, Inc.

CIK 1040188 San Antonio, TX

Position in MDXG

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,025,791

-$333,476 QoQ

Shares Held

259,694

+29.3% QoQ

Ownership

0.174%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 91.33595693392994.ToString("F0")% Shared 0.ToString("F0")% None 8.664043066070066.ToString("F0")%

Healthcare · as of Mar 31, 2026

VICTORY CAPITAL MANAGEMENT INC holds $2,018,555,898 across 156 Biotechnology names. MDXG ranks #72 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,888,521	$843,300,167
2	RPRX	Royalty Pharma plc	3,853,808	$184,867,169
3	INCY	Incyte Corp	1,742,870	$164,038,924
4	REGN	Regeneron Pharmaceuticals, Inc.	129,074	$99,727,735
5	ALNY	Alnylam Pharmaceuticals, Inc.	195,937	$64,829,675
6	INSM	INSMED Inc	396,245	$64,793,982
7	LGND	Ligand Pharmaceuticals Inc	303,224	$60,538,671
8	JAZZ	Jazz Pharmaceuticals plc	256,598	$48,509,851

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,025,791	259,694	+29.3%	Shares	Sole	2026-05-15
2025-12-31	$1,359,267	200,778	+7.5%	Shares	Sole	2026-02-13
2025-09-30	$1,303,256	186,713	+7.6%	Shares	Sole	2025-11-12
2025-06-30	$1,060,042	173,493	+29.9%	Shares	Sole	2025-08-13
2025-03-31	$1,015,010	133,554	-2.8%	Shares	Sole	2025-05-02
2024-12-31	$1,321,393	137,359	-3.5%	Shares	Sole	2025-02-06
2024-09-30	$841,288	142,350	+2.8%	Shares	Sole	2024-11-05
2024-06-30	$959,451	138,449	+909.0%	Shares	Sole	2024-08-05
2024-03-31	$105,659	13,722	-8.0%	Shares	Sole	2024-05-03
2023-12-31	$130,813	14,916	+23.1%	Shares	Sole	2024-02-05
2023-09-30	$88,354	12,120	—	Shares	Sole	2023-11-06
No filing history on record for this holder in this stock.